Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT03473860
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent;
* First diagnosis of CAD through CAG;
* Aged 45-70.
Exclusion Criteria:
* Patients with severe liver or kidney damage;
* Taking statins within the last 3 months;
* Patients who had been diagnosed with CAD and treated with oral medication;
* Chronic diseases of the blood system;
* Familial hyperlipidemia patients;
* Patients combining autoimmune disease;
* Patients combining acute infectious disease;
* Patients who undertaken surgery or injury;
* Patients who combining cancer;
* Patients who taking glucocorticoid replacement therapy;
* Abnormal red blood cell (RBC) count (M: \<4.0 or \>5.5 × 1012/L; F: \<3.5 or \>5.0 × 1012/L) or abnormal hemoglobin (M: \<120 or \>160 g/L; F: \<110 or \>150 g/L).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
70 Years
Study:
NCT03473860
Study Brief:
Protocol Section:
NCT03473860